Mark W. Reynolds
2017
In 2017, Mark W. Reynolds earned a total compensation of $266.9K as Chief Financial Officer at GeoVax Labs, a 4% increase compared to previous year.
Compensation breakdown
| Option Awards | $29,250 |
|---|---|
| Salary | $234,392 |
| Other | $3,281 |
| Total | $266,923 |
Reynolds received $234.4K in salary, accounting for 88% of the total pay in 2017.
Reynolds also received $29.3K in option awards and $3.3K in other compensation.
Rankings
In 2017, Mark W. Reynolds' compensation ranked 13,590th out of 14,666 executives tracked by ExecPay. In other words, Reynolds earned more than 7.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,590 out of 14,666 | 7th |
Division Manufacturing | 5,336 out of 5,768 | 8th |
Major group Chemicals And Allied Products | 1,922 out of 2,074 | 7th |
Industry group Drugs | 1,604 out of 1,730 | 7th |
Industry Pharmaceutical Preparations | 1,228 out of 1,329 | 8th |
Source: SEC filing on April 27, 2018.
Reynolds' colleagues
We found two more compensation records of executives who worked with Mark W. Reynolds at GeoVax Labs in 2017.